title: [Cerebral aspergillosis in an human immunodeficiency virus infected patient].
authors.forename: Sergio
authors.initials: S
authors.lastname: Reus-Bañuls
authors.forename: Sonia
authors.initials: S
authors.lastname: Bustos Terol
authors.forename: Elena
authors.initials: E
authors.lastname: Caro-Martínez
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Cama-Barbieri
mesh_terms: D015492:AIDS Serodiagnosis; D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001929:Brain Edema / Q000209:etiology; D003586:Cytomegalovirus Infections / Q000209:etiology; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008279:Magnetic Resonance Imaging; D009018:Morocco / Q000208:ethnology; D020953:Neuroaspergillosis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D016868:Serratia Infections / Q000209:etiology; D016781:Toxoplasmosis, Cerebral / Q000209:etiology; D014230:Triazoles / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole